O papel do farmacêutico na pandemia de COVID-19: Revisão integrativa

Márcia Maria Barros dos  Passos; Vivien de Moraes Castoldi; Orenzio Soler

doi:10.33448/rsd-v10i6.15809

Autores/as

Márcia Maria Barros dos Passos Universidade Federal do Rio de Janeiro https://orcid.org/0000-0002-0416-6273
Vivien de Moraes Castoldi Universidade Federal do Rio de Janeiro https://orcid.org/0000-0002-7727-8487
Orenzio Soler Universidade Federal do Pará https://orcid.org/0000-0003-2246-0019

DOI:

https://doi.org/10.33448/rsd-v10i6.15809

Palabras clave:

Coronavirus; COVID-19; Servicio de farmacia; Atención farmacéutica; Farmacia hospitalaria.

Resumen

Objetivo: Analizar la literatura científica sobre el papel del farmacéutico en la pandemia de COVID-19, a través de una revisión integradora de la literatura. Fuente de datos: La búsqueda de artículos científicos se realizó en las siguientes bases de datos: Biblioteca Virtual en Salud (BVS), Literatura Latinoamericana y del Caribe en Ciencias de la Salud (LILACS), Biblioteca Electrónica Científica en Línea (SciELO) y PubMed en el período de 2019 a 2020. Los criterios de inclusión establecidos fueron publicaciones en inglés con el descriptor “Coronavirus, COVID-19, Farmacia, Farmacia Comunitaria, Servicios de Farmacia, Atención Farmacéutica, Farmacia Hospitalaria” en el título, resumen o palabras clave en los artículos disponibles online y completos. Se excluyeron las cartas al editor y los artículos duplicados. Resumen de los hallazgos: Se identificaron 10.906 artículos, de los cuales 28 cumplieron con los criterios de selección. Los resultados se demostraron con énfasis en las funciones adicionales que desempeñan los farmacéuticos tanto en la farmacia comunitaria como en la farmacia hospitalaria, determinadas por la situación pandémica. A nivel hospitalario se verificó el apoyo a la toma de decisiones clínicas sobre farmacoterapia, gestión logística de medicamentos, mayor seguridad en la dispensación de medicamentos y farmacovigilancia. En el entorno de la farmacia comunitaria, se hizo hincapié en la atención farmacéutica directamente al usuario a través de la orientación sobre medidas de higiene que buscan minimizar o prevenir la propagación del virus y la contaminación de las personas. Mantener la dispensación de medicamentos para usuarios agudos y crónicos, garantizando el suministro y disponibilidad de medicamentos de calidad, fue la actividad principal, así como las pruebas rápidas para el diagnóstico de COVID-19.

Citas

Al-Quteimat, O., Amer, A. M. (2021). SARS-CoV-2 outbreak: How can pharmacists help? Res Social Adm Pharm, 17(2), 480-482. https://doi.org/10.1016/j.sapharm.2020.03.018.

Alderman, C. Pharmacy Services and the Novel Coronavirus. (2020). Sr Care Pharm, 35(4), 146-147. https://doi.org/10.4140/TCP.n.2020.146

Amariles, P., Ledezma-Morales, M., Salazar-Ospina, A., Hincapié-Garcia, J. A., (2021). How to link patients with suspicious COVID-19 to health system from the community pharmacies? A route proposal. Res Social Adm Pharm, 17(1), 1988-1989. https://doi.org/10.1016/j.sapharm.2020.03.007.

Arain,S., Thalapparambayh, R., Al Ghandi, F. H. (2020). COVID-19 pandemic: Response plan by the Johns Hopkins Aramco Healthcare inpatient pharmacy department. Res Social Adm Pharm, 17(1), 2009-2011.

https://doi.org/10.1016/j.sapharm.2020.05.016.

Bahlol, M., Dewey, R. S. (2020). Pandemic preparedness of community pharmacies for COVID-19. Res Social Adm Pharm, 17(1), 1888-1898. https://doi.org/10.1016/j.sapharm.2020.05.009.

Basheti,I. A., Nassar, R., Barakat, M., Alqudah, R., Abufarha, T., Mukattash, L., Saini, B. (2020). Pharmacists’ readiness to deal with the coronavirus pandemic: Assessing awareness and perception of roles. Res Social Adm Pharm, 17(3), 514-522. https://doi.org/10.1016/j.sapharm.2020.04.020.

Bukhari, N., Rasheed, U., Nayyer, B., Babar, Z. U. D. (2020). Pharmacists at the frontline beating the COVID-19 pandemic. J of Pharm Policy and Pract 13, 8 (2020). https://doi.org/10.1186/s40545-020-00210-w.

Cadogan, C. A., Hughes, C. M. (2020). On the frontline against COVID-19: Community pharmacists’ contribution during a public health crisis. Res Social Adm Pharm, 17(3), 514-522. DOI:10.1186/s40545-020-00210-w

Carico, R., Sheppatd, J., Thomas, C. B. (2021). Community pharmacists and communication in the time of COVID-19: Applying the health belief model. Res Social Adm Pharm, 17(1), 1984-1987. https://doi.org/10.1016/j.sapharm.2020.03.017.

Dawoud, D. (2021). Emerging from the other end: Key measures for a successful COVID-19 lockdown exit strategy and the potential contribution of pharmacists. Res Social Adm Pharm, 17(1): 1950–1953. https://doi.org/10.1016/j.sapharm.2020.05.011.

Erku, D. A., Belachew, S. A., Abrha, S., Sinnollareddy, M., Thomas, J., Steadman, K. J., Tesfaye, H. (2020). When fear and misinformation go viral: Pharmacists’ role in deterring medication misinformation during the “infodemic” surrounding COVID-19. Res Social Adm Pharm, 17(1), 1954-1963. https://doi.org/10.1016/j.sapharm.2020.04.032.

Fitzgerald, T.J. Kang, Y., Bridges, C. B., Talbert, T., Vagi, S. J., Lamont, B., Gratcer, S. B. (2016). Integrating pharmacies into public health program planning for pandemic influenza vaccine response. Vaccine, 34(46), 5643–5648. https://doi.org/10.1016/j.vaccine.2016.09.020.

Hedima, E. W., Adeyemi, M. S,m Ikunaiye, N. Y.(2020). Community Pharmacists: On the frontline of health service against COVID-19 in LMICs. Res Social Adm Pharm, 17(1), 1964-1966. https://doi.org/10.1016/j.sapharm.2020.04.013

Hua, X. L., Gu, M., Zeng, F., Hu, H., Zhou, T., Zhang, Y., Shi, C. (2020) Pharmacy administration and pharmaceutical care practice in a module hospital during the COVID-19 epidemic. J Am Pharm Assoc, 60(3), 431- 438. https://doi.org/10.1016/j.japh.2020.04.006.

Hussain, R., Dawoud, D. M., Babar, Z. U. D. (2020). Drive-thru pharmacy services: A way forward to combat COVID-19 pandemic. Res Social Adm Pharm, 17(1), 1920-1924. https://doi.org/10.1016/j.sapharm.2020.07.015.

International Pharmaceutical Federation (FIP Health Advisory). Coronavirus 2019-nCoV Outbreak. Information and interim guidelines for pharmacists and the pharmacy workforce. Netherlands, 2020. Disponível em:: https://www.fip.org/files/content/priority-areas/coronavirus/Coronavirus-guidance-update-ENGLISH.pdf. Acesso em: 30 out 2020.

Jiang,S. Death Toll Rises to 25. CNN; 2020. Disponível em: https://edition.cnn.com/asia/live-news/coronavirus-outbreak-intl-hnk/index.html. Acesso em: 29 out 2020.

Koster, E., Philbert, D., Bouvy, M. L.(2021). Impact of the COVID-19 epidemic on the provision of pharmaceutical care in community pharmacies. Res Social Adm Pharm,17(1), 2002-2004.

https://doi.org/10.1016/j.sapharm.2020.07.001.

Li, H., Sigian, Z., Fang, L., Wei, L., Rongsheng, Z. (2021) Fighting against COVID-19: Innovative strategies for clinical pharmacists. Res Social Adm Pharm, 17(1), 1813-1818. https://doi.org/10.1016/j.sapharm.2020.07.001.

Liu, S., Luo, P., Tang, M., Hu, Q., Polidoro, J. P., Sun, S., Gong, Z. (2020). Providing pharmacy services during the coronavirus pandemic. Int J Clin Pharm, 42(2):299-304.

https://doi.org/10.1007/s11096-020-01017-0.

Lu, C., Liu, X., Jia, Z. (2020). 2019-nCoV transmission through the ocular surface must not be ignored.

Lancet, 22(395) (10224):e39. https://doi.org/10.1016/S0140-6736(20)30313-5.

Meng, L., Qiu, F., Sun, S. (2020). Providing pharmacy services at cabin hospitals at the coronavirus epicenter in China. Int J Clin Pharm, 2 : 1–4. https://doi.org/10.1007/s11096-020-01020-5.

Santos, L. E. S. dos; Santos, L. S. dos. (20210. The impact of the coronavirus on patients with heart diseases. Research, Society and Development, 10(5), e0110514539.

https://doi.org/10.33448/rsd-v10i5.14539.

Sethuraman, N., (2020). Interpreting diagnostic tests for SARS-CoV-2. JAMA. 6, 2020. https://doi.org/10.1001/jama.2020.8259.

Song, Z., Hu, Y., Zheng, S., Yang, L., Zhao, R. (2021). Hospital pharmacists’ pharmaceutical care for hospitalized patients with COVID-19: Recommendations and guidance from clinical experience. Res Social Adm Pharm, 17(1):2027-2031. https://doi.org/10.1016/j.sapharm.2020.03.027.

Souza, M. T., Silva, M. D., Carvalho, R. (2010). Integrative review: what is it? How to do it?. Einstein, 6(1), 102-6. https://doi.org/10.1590/s1679-45082010rw1134

Stergachis, A. (2020). Preparing pharmacy for the surge of patients with COVID-19: Lessons from China. J Am Pharm Assoc, 60(3): 423–424. https://doi.org/10.1016/j.japh.2020.04.005.

Sum, Z. Z., OW, C. J. W. (2021). Community pharmacy response to infection control during COVID-19. A cross-sectional survey. Res Social Adm Pharm, 17(1):1845-1852.

https://doi.org/10.1016/j.sapharm.2020.06.014.

The Straits Times. First Death outside China in Philippines; 2020. Published https ://www.straitstimes.com/asia/se-asia/first-death-outside-china-in-philippines. Acesso em: 28 out 2020.

Ung, C. O. L. (2020). Community pharmacist in public health emergencies: Quick to action against the coronavirus 2019-nCoV outbreak. Res Social Adm Pharm, 16(4):583-586.

https://doi.org/10.1016/j.sapharm.2020.02.003.

Uzunian, A. (2020). Coronavírus SARS-CoV-2 e COVID-19. J Bras Patol Med Lab, 56: 1-4.

Vellano, P. O., Paiva, M. J. M. (2020). O uso de antimicrobiano na COVID-19 e as infecções: o que sabemos. Research, Society and Development, 9(6), e841997245. http://dx.doi.org/10.33448/rsd-v9i9.7245

Visacri, M. B., Figueiredo, I. V., Lima, T. M.(2021). Role of pharmacist during the COVID-19 pandemic: A scoping review. Res Social Adm Pharm, 17(1), 1799-1806. https://doi.org/10.1016/j.sapharm.2020.07.003.

Wiersinga, W. J., Rodhes, A., Cheng, A. C., Peacock, S., Prescott, H. C. (2020). Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review. JAMA, 324(8), 782-793. https://doi.org/10.1001/jama.2020.12839.

World Health Organization. Modes of Transmission of Virus Causing COVID-19: Implications for IPC Precaution Recommendations. https://www.who.int/news-room/commentaries/detail/m odes-of-transmission-of-virus-causing-covid-19-implications-for-ipc-precaution-r ecommendations. Acesso em: 28 out 2020.

Ying,W., Qian, Y., Kun, Z. (2021). Drugs supply and pharmaceutical care management practices at a designated hospital during the COVID-19 epidemic. Res Social Adm Pharm, 17(1), 1978-1983.

https://doi.org/1010.1016/j.sapharm.2020.04.001.

World Heath Organization. Coronavirus Disease (COVID-19) - events as they happen. Disponível em: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/events-as-they-happen. Acesso em: 28 out 2020.

World Heath Organization. Coronavirus disease 2019 (COVID-19) - situation report – 72. Disponível em: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200401-sitrep-72-c ovid-19.pdf?sfvrsn¼3dd8971b_2; 2020b. Acesso em: 28 out 2020.

Zaidi, S. T. R., Hasan, S., Saidi, S. T. R., Hasan, S. S.(2020). Personal protective practices and pharmacy services delivery by community pharmacists during COVID-19 pandemic: Results from a national survey. Res Social Adm Pharm, 17(1), 1832-1837. https://doi.org/10.1016/j.sapharm.2020.07.006.

Zheng, S., Yang, L., Zhou, P. X., Li, H., Liu, F. (2021). Recommendations and guidance for providing pharmaceutical care services during COVID-19 pandemic: A China perspective. Res Social Adm Pharm, 17(1), 1819-1824. https://doi.org/10.1016/j.sapharm.2020.03.012

Zuckerman, A. D., (2020). From natural disaster to pandemic: A health-system pharmacy rises to the challenge. Am J Health Syst Pharm, 77(23), 1986–1993. https://doi.org/10.1093/ajhp/zxaa180.

El papel del farmacéutico en la pandemia de COVID-19: Una revisión integradora

Autores/as

DOI:

Palabras clave:

Resumen

Citas

Descargas

Publicado

Cómo citar

Número

Sección

Licencia

JOURNAL METRICS

Idioma

Enviar un artículo